Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
48 studies found for:    alzheimer's OR alzheimer's disease | Open Studies | NIH
Show Display Options
RSS Create an RSS feed from your search for:
alzheimer's OR alzheimer's disease | Open Studies | NIH
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Meganatural-Az Grapeseed Extract;   Drug: Placebo
2 Recruiting Alzheimer's Disease Genetics Study
Conditions: Alzheimer Disease;   Late Onset Alzheimer Disease;   Dementia
Intervention:
3 Recruiting Sleep, Aging and Risk for Alzheimer's Disease
Conditions: Sleep Disordered Breathing;   Alzheimer's Disease
Intervention: Device: Continuous positive airway pressure (CPAP)
4 Recruiting Alzheimer's Prevention Through Exercise
Condition: Alzheimer's Disease
Interventions: Other: Aerobic Exercise;   Other: Standard of Care
5 Recruiting Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease
Condition: Genetic Risk for Alzheimer's Disease
Interventions: Drug: donepezil HCL;   Drug: Placebo
6 Recruiting Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
Condition: Dementia Alzheimer's Type
Interventions: Drug: Sargramostim GZ402664;   Drug: Placebo;   Drug: Florbetapir F18
7 Recruiting Dominantly Inherited Alzheimer Network (DIAN)
Condition: Alzheimer's Disease
Intervention:
8 Recruiting Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD
Conditions: Mild Cognitive Impairment;   Alzheimer Disease
Interventions: Drug: Allopregnanolone injection (intravenous solution);   Drug: Placebo injection (intravenous solution)
9 Recruiting Treatment of Psychosis and Agitation in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Psychosis;   Agitation
Interventions: Drug: Lithium;   Drug: Placebo
10 Not yet recruiting The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression
Conditions: Alzheimer's Disease;   Dementia
Interventions: Other: Placebo;   Other: Medication Therapy Management (MTM);   Drug: Scopolamine patch
11 Recruiting Alzheimer's Caregiver Coping: Mental and Physical Health
Conditions: Alzheimer Disease;   Alzheimer Dementia;   Alzheimer's Disease;   Dementia
Interventions: Behavioral: Behavioral Activation;   Behavioral: Information and Support
12 Recruiting Bisnorcymserine in Healthy Adult Volunteers
Condition: Alzheimer's Disease
Intervention: Drug: BNC
13 Recruiting Human Brain Antioxidants During Oxidative Stress
Conditions: Oxidative Stress;   Alzheimer's Disease;   Aging
Intervention:
14 Recruiting Arterial Spin Labeling (ASL) MRI for Cognitive Decline
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Interventions: Drug: FDG-PET;   Other: ASL-MRI;   Procedure: Lumbar Puncture
15 Recruiting Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline
Conditions: Alzheimer's Disease;   Cognitive Impairment
Intervention: Other: Mediterranean Diet
16 Recruiting Apathy in Dementia Methylphenidate Trial 2
Conditions: Apathy;   Alzheimer's Disease
Interventions: Drug: Methylphenidate;   Drug: Placebo
17 Recruiting Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function
Conditions: Alzheimer's Disease;   Obesity;   Diabetes Mellitus
Interventions: Dietary Supplement: Boost A;   Behavioral: Healthy Living Diet
18 Recruiting Imaging of Cognition, Learning, and Memory in Aging
Condition: Alzheimer's Disease
Intervention: Drug: Florbetaben
19 Recruiting Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
Conditions: Alzheimer Disease;   Mild Cognitive Impairment;   Delirium, Dementia, Amnestic, Cognitive Disorders
Intervention: Drug: Donepezil
20 Recruiting A Study of Crenezumab Versus Placebo in Preclinical PSEN1 E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer Disease (AD), Including a Placebo-Treated Noncarrier Cohort
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.